Explore how G-quadruplex DNA structures are becoming promising targets for revolutionary cancer therapies by regulating oncogenes and enabling targeted treatments.
Discover how LEM-06, the first NSD2 inhibitor, is revolutionizing epigenetic cancer therapy and offering new hope for multiple myeloma patients.
Discover how 2-thioxanthine inhibits DNA glycosylases by targeting zinc fingers, opening new possibilities for cancer therapy through synthetic lethality approaches.
How scientists are building an automated factory for Bismuth-213, one of nature's most powerful cancer-fighting weapons in Targeted Alpha Therapy.
Discover how the structural breakthrough of Folate Receptor Alpha (FRα) has revolutionized targeted cancer therapies, enabling precision treatments for ovarian, lung, and other carcinomas.
Breakthrough nanocomposite CaO₂–MnO₂–UCNPs–Ce6/DOX (CaMn–NUC) is revolutionizing cancer therapy by manufacturing oxygen on demand while dismantling cancer's defenses.
Explore how Janus dendrimers are transforming cancer treatment by delivering ibuprofen and chlorambucil simultaneously with precision targeting.
Exploring how ruthenium complexes are emerging as promising alternatives to platinum-based cancer therapies with improved targeting and reduced side effects.
Exploring how DNA methylation inhibitors are transforming cancer treatment through epigenetic reprogramming of tumor cells.
Exploring Stosh Kozimor's groundbreaking research on radioactive actinides and their applications in energy and medicine.